Variant report

Variant	nsv581837
Chromosome Location	chr2:50230334-50268616
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr2:50231721-50232233	H1-hESC	embryonic stem cell:	n/a	n/a
2	BCL11A	chr2:50231801-50232131	H1-hESC	embryonic stem cell:	n/a	n/a
3	BCL11A	chr2:50231774-50232182	H1-hESC	embryonic stem cell:	n/a	n/a
4	CEBPB	chr2:50241425-50241630	K562	blood:	n/a	chr2:50241549-50241560 chr2:50241528-50241539
5	CEBPB	chr2:50245918-50246489	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr2:50231680-50232224	H1-hESC	embryonic stem cell:	n/a	n/a
7	CEBPB	chr2:50241390-50241721	Hela-S3	cervix:	n/a	chr2:50241549-50241560 chr2:50241528-50241539
8	CEBPB	chr2:50241413-50241705	IMR90	lung:	n/a	chr2:50241549-50241560 chr2:50241528-50241539
9	CEBPB	chr2:50241438-50241669	H1-hESC	embryonic stem cell:	n/a	chr2:50241549-50241560 chr2:50241528-50241539
10	CEBPB	chr2:50246112-50246386	H1-hESC	embryonic stem cell:	n/a	n/a
11	CEBPB	chr2:50241380-50241726	A549	lung:	n/a	chr2:50241549-50241560 chr2:50241528-50241539
12	CEBPB	chr2:50241365-50241718	HepG2	liver:	n/a	chr2:50241549-50241560 chr2:50241528-50241539
13	CEBPB	chr2:50246112-50246411	HepG2	liver:	n/a	n/a
14	CHD2	chr2:50246157-50246357	Hela-S3	cervix:	n/a	n/a
15	CHD2	chr2:50231743-50232235	H1-hESC	embryonic stem cell:	n/a	n/a
16	CHD2	chr2:50233483-50233817	H1-hESC	embryonic stem cell:	n/a	n/a
17	CREB1	chr2:50231699-50232246	H1-hESC	embryonic stem cell:	n/a	n/a
18	CTCF	chr2:50242303-50242412	LNCaP	prostate:	n/a	n/a
19	CTCF	chr2:50242328-50242373	LNCaP	prostate:	n/a	n/a
20	E2F4	chr2:50235995-50236054	MCF10A-Er-Src	breast:	n/a	n/a
21	E2F4	chr2:50246109-50246340	MCF10A-Er-Src	breast:	n/a	n/a
22	EP300	chr2:50266622-50266833	SK-N-SH_RA	brain:	n/a	n/a
23	EP300	chr2:50231661-50232295	H1-hESC	embryonic stem cell:	n/a	n/a
24	EP300	chr2:50249956-50250058	GM12878	blood:	n/a	n/a
25	EP300	chr2:50246059-50246447	Hela-S3	cervix:	n/a	chr2:50246254-50246268
26	EP300	chr2:50266645-50266872	SK-N-SH_RA	brain:	n/a	n/a
27	EP300	chr2:50266517-50267135	SK-N-SH	brain:	n/a	chr2:50266883-50266891
28	FOS	chr2:50246004-50246475	MCF10A-Er-Src	breast:	n/a	chr2:50246199-50246211
29	FOS	chr2:50246040-50246476	MCF10A-Er-Src	breast:	n/a	chr2:50246199-50246211
30	FOS	chr2:50245946-50246474	MCF10A-Er-Src	breast:	n/a	chr2:50246199-50246211
31	FOS	chr2:50246060-50246463	MCF10A-Er-Src	breast:	n/a	chr2:50246199-50246211
32	GATA2	chr2:50266597-50266977	SH-SY5Y	brain:	n/a	chr2:50266825-50266842 chr2:50266829-50266850 chr2:50266836-50266843 chr2:50266831-50266847 chr2:50266834-50266843
33	GATA3	chr2:50266677-50267063	SH-SY5Y	brain:	n/a	chr2:50266825-50266842 chr2:50266829-50266850 chr2:50266836-50266843 chr2:50267013-50267025 chr2:50266831-50266847 chr2:50266834-50266843
34	GTF2F1	chr2:50232021-50232107	H1-hESC	embryonic stem cell:	n/a	n/a
35	HDAC2	chr2:50231782-50232248	H1-hESC	embryonic stem cell:	n/a	chr2:50232219-50232233
36	JUN	chr2:50231851-50232374	H1-hESC	embryonic stem cell:	n/a	n/a
37	JUN	chr2:50246151-50246351	H1-hESC	embryonic stem cell:	n/a	chr2:50246254-50246267 chr2:50246199-50246211 chr2:50246239-50246252
38	JUN	chr2:50264659-50264798	K562	blood:	n/a	n/a
39	JUN	chr2:50233678-50233778	H1-hESC	embryonic stem cell:	n/a	n/a
40	JUN	chr2:50246109-50246397	HepG2	liver:	n/a	chr2:50246254-50246267 chr2:50246199-50246211 chr2:50246239-50246252
41	JUN	chr2:50246107-50246425	Hela-S3	cervix:	n/a	chr2:50246254-50246267 chr2:50246199-50246211 chr2:50246239-50246252
42	JUND	chr2:50246095-50246413	HepG2	liver:	n/a	chr2:50246199-50246211
43	JUND	chr2:50231782-50232070	H1-hESC	embryonic stem cell:	n/a	n/a
44	JUND	chr2:50244756-50244966	HepG2	liver:	n/a	chr2:50244859-50244866 chr2:50244858-50244867 chr2:50244857-50244868 chr2:50244859-50244867 chr2:50244859-50244868
45	JUND	chr2:50231758-50232331	H1-hESC	embryonic stem cell:	n/a	n/a
46	JUND	chr2:50233464-50233716	H1-hESC	embryonic stem cell:	n/a	n/a
47	JUND	chr2:50246175-50246440	H1-hESC	embryonic stem cell:	n/a	chr2:50246199-50246211
48	JUND	chr2:50246092-50246407	Hela-S3	cervix:	n/a	chr2:50246199-50246211
49	KAP1	chr2:50245328-50246485	U2OS	brain:	n/a	n/a
50	MAFK	chr2:50231759-50232138	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:50232611-50232661	GM12892	blood:	n/a
2	chr2:50234533-50234583	BJ	skin:	n/a
3	chr2:50232611-50232661	SK-N-SH_RA	brain:	n/a
4	chr2:50232611-50232661	ProgFib	skin:	n/a
5	chr2:50232611-50232661	H1-hESC	embryonic stem cell:	embryo
6	chr2:50232611-50232661	HCF	heart:	n/a
7	chr2:50232611-50232661	MCF-7	breast:	n/a
8	chr2:50232611-50232661	Caco-2	colon:	n/a
9	chr2:50234533-50234583	HIPEpiC	eye:	n/a
10	chr2:50234533-50234583	AG04449	skin:	fetal
11	chr2:50232611-50232661	HAEpiC	amniotic membrane:	n/a
12	chr2:50234533-50234583	SK-N-MC	brain:	n/a
13	chr2:50232611-50232661	AoSMC	blood vessel:	n/a
14	chr2:50234533-50234583	Jurkat	blood:	n/a
15	chr2:50234533-50234583	LNCaP	prostate:	n/a
16	chr2:50234533-50234583	SK-N-SH_RA	brain:	n/a
17	chr2:50232611-50232661	HCT-116	colon:	n/a
18	chr2:50232611-50232661	HL-60	blood:	n/a
19	chr2:50232611-50232661	GM06990	blood:	n/a
20	chr2:50234533-50234583	HRE	kidney:	n/a
21	chr2:50234533-50234583	CMK	blood:	n/a
22	chr2:50232611-50232661	HCPEpiC	choroid plexus:	n/a
23	chr2:50232611-50232661	HEEpiC	esophagus:	n/a
24	chr2:50232611-50232661	HCM	heart:	n/a
25	chr2:50234533-50234583	HCT-116	colon:	n/a
26	chr2:50232611-50232661	LNCaP	prostate:	n/a
27	chr2:50232611-50232661	SKMC	muscle:	n/a
28	chr2:50232611-50232661	NHBE	bronchial:	n/a
29	chr2:50234533-50234583	H1-hESC	embryonic stem cell:	embryo
30	chr2:50232611-50232661	PFSK-1	brain:	n/a
31	chr2:50234533-50234583	HPAEpiC	pulmonary alveolar:	n/a
32	chr2:50234533-50234583	NHDF-neo	bronchial:	n/a
33	chr2:50232611-50232661	NH-A	brain:	n/a
34	chr2:50234533-50234583	GM06990	blood:	n/a
35	chr2:50234533-50234583	NB4	blood:	n/a
36	chr2:50234533-50234583	AG10803	skin:	n/a
37	chr2:50234533-50234583	AG04450	lung:	fetal
38	chr2:50232611-50232661	RPTEC	kidney:	n/a
39	chr2:50232611-50232661	AG10803	skin:	n/a
40	chr2:50232611-50232661	HRPEpiC	eye:	n/a
41	chr2:50232611-50232661	Jurkat	blood:	n/a
42	chr2:50234533-50234583	SK-N-SH	brain:	n/a
43	chr2:50232611-50232661	AG04449	skin:	fetal
44	chr2:50232611-50232661	NB4	blood:	n/a
45	chr2:50232611-50232661	HIPEpiC	eye:	n/a
46	chr2:50232611-50232661	BJ	skin:	n/a
47	chr2:50234533-50234583	HEK293	kidney:	embryo
48	chr2:50232611-50232661	Hepatocyte	liver:	n/a
49	chr2:50234533-50234583	AoSMC	blood vessel:	n/a
50	chr2:50234533-50234583	NH-A	brain:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:49987705..49990073-chr2:50256678..50259583,2	K562	blood:
2	chr2:50245424..50247273-chr2:50250002..50252375,2	K562	blood:

Variant related genes	Relation type
NRXN1	TF binding region
NRXN1	CpG island
ENSG00000179915	chromatin interactions

Extended variants
information (count: 1368 )
Associated
traits (count: 104 )

Variant overlapped rSNPs/rCNVs (count:1368 , 50 per page) page: 1 2 3 4 5 6 7 ... 28

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7604754	chr2:50230334-50230335	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs187224854	chr2:50230583-50230584	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs529719915	chr2:50230594-50230595	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs191643140	chr2:50230659-50230660	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs1435091	chr2:50230685-50230686	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs549485519	chr2:50230723-50230724	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs570026677	chr2:50230737-50230738	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs1865488	chr2:50230781-50230782	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs528930610	chr2:50230793-50230794	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs544230937	chr2:50230798-50230799	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs367920209	chr2:50230799-50230800	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs562429271	chr2:50230870-50230871	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs1865489	chr2:50230912-50230913	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs1865490	chr2:50230916-50230917	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs566690162	chr2:50230918-50230919	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs138097394	chr2:50230920-50230921	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs565863847	chr2:50230954-50230955	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs549296888	chr2:50231060-50231061	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs142687451	chr2:50231084-50231085	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs1421577	chr2:50231111-50231112	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs556944106	chr2:50231134-50231135	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs548256275	chr2:50231225-50231226	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs553634302	chr2:50231228-50231229	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs10185922	chr2:50231290-50231291	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs59887674	chr2:50231294-50231295	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs557502218	chr2:50231306-50231307	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs368319782	chr2:50231342-50231343	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs540467715	chr2:50231378-50231379	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs555884495	chr2:50231402-50231403	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs574396370	chr2:50231434-50231435	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs150609732	chr2:50231507-50231508	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs10173664	chr2:50231543-50231544	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs139711244	chr2:50231559-50231560	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs545161293	chr2:50231572-50231573	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs559980689	chr2:50231574-50231575	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs11893341	chr2:50231577-50231578	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs183044573	chr2:50231579-50231580	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs567413641	chr2:50231603-50231604	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs576430302	chr2:50231611-50231612	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs1421578	chr2:50231612-50231613	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs2216521	chr2:50231614-50231615	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs568938965	chr2:50231632-50231633	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs35469732	chr2:50231636-50231637	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs149796248	chr2:50231638-50231639	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs188559773	chr2:50231654-50231655	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs112599384	chr2:50231699-50231700	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs77117792	chr2:50231792-50231793	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs534259185	chr2:50231805-50231806	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs144757955	chr2:50231839-50231840	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs2193865	chr2:50231869-50231870	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:104)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Bladder cancer	21909424	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	16272173	CNVD
Lung cancer	17297452	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20433910	CNVD
Autism	21701786	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	20553308	CNVD
Autism	22241247	CNVD
Myelofibrosis	22110671	CNVD
Lung adenocarcinoma	17086460	CNVD
Retinoblastoma	22278416	CNVD
Cancer	21183584	CNVD
Breast cancer	16397240	CNVD
Acute lymphoblastic leukemia	18768390	CNVD
Mental retardation	19521722	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	18940311	CNVD
Schizophrenia	19348701	CNVD
Schizophrenia	18945720	CNVD
Schizophrenia	19571808	CNVD
Prostate cancer	16573809	CNVD
Neuroticism	17667963	CNVD
Schizophrenia	19443537	CNVD
Schizophrenia	19546859	CNVD
Autism	17322880	CNVD
Lung cancer	17086460	CNVD
Chronic lymphocytic leukemia	17053054	CNVD
Hereditary non-polyposis colorectal cancer	19566914	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Basal cell lymphoma	21115979	CNVD
Cognitive impairment	21505072	CNVD
Psychiatric disorder	19734545	CNVD
Autism	20844286	CNVD
Schizophrenia	20838587	CNVD
Schizophrenia	20718829	CNVD
Autism	19218893	CNVD
Autism	22209245	CNVD
Neuropsychiatric disorder	21827697	CNVD
Schizophrenia	22118685	CNVD
Autism	20663923	CNVD
Schizophrenia	21285140	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21990379	CNVD
Schizophrenia	22885689	CNVD
Autism	20964600	CNVD
Schizophrenia	19521646	CNVD
Attention deficit hyperactivity disorder	22214315	CNVD
Chronic motor tic disorder	22214315	CNVD
Schizophrenia	22214315	CNVD
Mental retardation	19896112	CNVD

Chromatin state (count:101 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:50223400-50233000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr2:50227400-50232600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
3	chr2:50229200-50231800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
4	chr2:50229200-50234200	Enhancers	ES-I3 Cell Line	embryonic stem cell
5	chr2:50229400-50231400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
6	chr2:50229600-50231200	Weak transcription	HUES6 Cell Line	embryonic stem cell
7	chr2:50229800-50230800	Weak transcription	HUES64 Cell Line	embryonic stem cell
8	chr2:50229800-50230800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
9	chr2:50229800-50230800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
10	chr2:50229800-50231000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
11	chr2:50230000-50231000	Weak transcription	HUES48 Cell Line	embryonic stem cell
12	chr2:50230000-50231200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
13	chr2:50230000-50232800	Weak transcription	H9 Cell Line	embryonic stem cell
14	chr2:50230200-50231200	Weak transcription	H1 Cell Line	embryonic stem cell
15	chr2:50230800-50231600	Enhancers	iPS-20b Cell Line	embryonic stem cell
16	chr2:50230800-50231600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
17	chr2:50230800-50234000	Enhancers	HUES64 Cell Line	embryonic stem cell
18	chr2:50231000-50232200	Enhancers	HUES48 Cell Line	embryonic stem cell
19	chr2:50231000-50234200	Enhancers	iPS-15b Cell Line	embryonic stem cell
20	chr2:50231200-50231400	Enhancers	H1 Cell Line	embryonic stem cell
21	chr2:50231200-50231800	Enhancers	HUES6 Cell Line	embryonic stem cell
22	chr2:50231200-50232000	Enhancers	iPS-18 Cell Line	embryonic stem cell
23	chr2:50231200-50233000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr2:50231400-50231800	Weak transcription	H1 Cell Line	embryonic stem cell
25	chr2:50231400-50232400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
26	chr2:50231400-50232600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
27	chr2:50231600-50232400	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
28	chr2:50231600-50232600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
29	chr2:50231600-50234000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
30	chr2:50231800-50232200	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
31	chr2:50231800-50232400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
32	chr2:50231800-50234400	Enhancers	H1 Cell Line	embryonic stem cell
33	chr2:50232000-50232400	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
34	chr2:50232200-50232600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
35	chr2:50232200-50234200	Enhancers	HUES6 Cell Line	embryonic stem cell
36	chr2:50232400-50234200	Enhancers	iPS-18 Cell Line	embryonic stem cell
37	chr2:50232400-50234200	Enhancers	iPS-20b Cell Line	embryonic stem cell
38	chr2:50232600-50233000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
39	chr2:50232600-50233000	Enhancers	HUES48 Cell Line	embryonic stem cell
40	chr2:50232600-50233600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
41	chr2:50232600-50234200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
42	chr2:50232800-50234200	Enhancers	H9 Cell Line	embryonic stem cell
43	chr2:50233000-50233200	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
44	chr2:50233000-50233400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
45	chr2:50233000-50233800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
46	chr2:50233000-50240000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr2:50233200-50234200	Enhancers	HUES48 Cell Line	embryonic stem cell
48	chr2:50233600-50234200	Enhancers	Brain Anterior Caudate	brain
49	chr2:50234000-50237400	Weak transcription	HUES64 Cell Line	embryonic stem cell
50	chr2:50234200-50237400	Weak transcription	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links